Skip to main content

Table 1 Demographic and clinical data of the studied groups

From: Relation of serum level of tumor necrosis factor-alpha to cognitive functions in patients with Parkinson’s disease

  Patients Control p value
Age (year) 63 ± 8 62 ± 4 0.45
Gender    
 Male 25 (83.3%) 25 (83.3%) 0.73
 Female 5 (16.7%) 5 (16.7%)  
Duration (year) 3 ± 1  
Age at onset of the disease 55 ± 7  
Total UPDRS score Range 23–77  
Mean 47
Median 45
HY scale Range 1–3  
Mean 2.4 ± 0.8
Median 2
Treatment    
 Dopaminergic drugs (22)73.3%  
 Untreated (5)16.7%   
 Non-compliant (3)10%   
  1. UPDRS Unified Parkinson’s Disease Rating Scale, HY Hoehn and Yahr